Description and Classification of Thyroid Cytology

  • Michael Rivera
  • Jennifer L. Sauter
  • Michael R. Henry
Part of the Contemporary Endocrinology book series (COE)


Cytopathology plays an important role in the evaluation of thyroid nodules. A variety of benign and malignant tumors may involve the thyroid gland, encompassing tumors of follicular and C cell origin to metastases from distant sites and lymphoma. The cytological features that distinguish benign from malignant thyroid tumors are discussed in this chapter, including descriptions of some of the more common diagnostic pitfalls. In addition, the Bethesda system for reporting thyroid cytopathology is discussed.


Bethesda Fine needle aspiration Papillary Medullary Follicular Pseudoinclusion Grooves Hurthle 


  1. 1.
    Wang C, Crapo LM. The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin N Am. 1997;26:189–218.CrossRefGoogle Scholar
  2. 2.
    Yamamoto Y, Maeda T, Izumi K, Otsuka H. Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer. 1990;65:1173–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Pelizzo MR, et al. High prevalence of occult papillary thyroid carcinoma in a surgical series for benign thyroid disease. Tumori. 1990;76:255–7.PubMedGoogle Scholar
  4. 4.
    Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer. 1985;56:531–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Rosai J, LiVolsi VA, Sobrinho-Simoes M, Williams ED. Renaming papillary microcarcinoma of the thyroid gland: the Porto proposal. Int J Surg Pathol. 2003;11:249–51.CrossRefPubMedGoogle Scholar
  6. 6.
    Rojeski MT, Gharib H. Nodular thyroid disease. Evaluation and management. N Engl J Med. 1985;313:428–36. doi: 10.1056/NEJM198508153130707.CrossRefPubMedGoogle Scholar
  7. 7.
    Gharib H. Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin Proc. 1994;69:44–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Hamberger B, Gharib H, Melton LJ 3rd, Goellner JR, Zinsmeister AR. Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med. 1982;73:381–4.CrossRefPubMedGoogle Scholar
  9. 9.
    Hamburger JI, Husain M. Semiquantitative criteria for fine-needle biopsy diagnosis: reduced false-negative diagnoses. Diagn Cytopathol. 1988;4:14–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Bakhos R, et al. Fine-needle aspiration of the thyroid: rate and causes of cytohistopathologic discordance. Diagn Cytopathol. 2000;23:233–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Hamburger JI. Diagnosis of thyroid nodules by fine needle biopsy: use and abuse. J Clin Endocrinol Metab. 1994;79:335–9. doi: 10.1210/jcem.79.2.8045944.PubMedGoogle Scholar
  12. 12.
    Giuffrida D, Gharib H. Controversies in the management of cold, hot, and occult thyroid nodules. Am J Med. 1995;99:642–50.CrossRefPubMedGoogle Scholar
  13. 13.
    Caruso D, Mazzaferri EL. Fine needle aspiration biopsy in the management of thyroid nodules. Endocrinologist. 1991;1:194–201.CrossRefGoogle Scholar
  14. 14.
    Hall TL, Layfield LJ, Philippe A, Rosenthal DL. Sources of diagnostic error in fine needle aspiration of the thyroid. Cancer. 1989;63:718–25.CrossRefPubMedGoogle Scholar
  15. 15.
    Renshaw AA. Accuracy of thyroid fine-needle aspiration using receiver operator characteristic curves. Am J Clin Pathol. 2001;116:477–82. doi: 10.1309/M3K5-23C2-455E-0HB5.CrossRefPubMedGoogle Scholar
  16. 16.
    Lloyd RV, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol. 2004;28:1336–40.CrossRefPubMedGoogle Scholar
  17. 17.
    Cibas ES, et al. A prospective assessment defining the limitations of thyroid nodule pathologic evaluation. Ann Intern Med. 2013;159:325–32. doi: 10.7326/0003-4819-159-5-201309030-00006.CrossRefPubMedGoogle Scholar
  18. 18.
    Baloch ZW, et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): a changing paradigm in thyroid surgical pathology and implications for thyroid cytopathology. Cancer Cytopathol. 2016;124:616–20. doi: 10.1002/cncy.21744.CrossRefPubMedGoogle Scholar
  19. 19.
    Nikiforov YE, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016;2:1023–9. doi: 10.1001/jamaoncol.2016.0386.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    de los Santos ET, Keyhani-Rofagha S, Cunningham JJ, Mazzaferri EL. Cystic thyroid nodules. The dilemma of malignant lesions. Arch Intern Med. 1990;150:1422–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Meko JB, Norton JA. Large cystic/solid thyroid nodules: a potential false-negative fine-needle aspiration. Surgery. 1995;118:996–1003; discussion 1003-1004.CrossRefPubMedGoogle Scholar
  22. 22.
    Lun Y, et al. Hashimoto’s thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngol Head Neck Surg. 2013;148:396–402. doi: 10.1177/0194599812472426.CrossRefPubMedGoogle Scholar
  23. 23.
    Nagataki S, Takamura N. A review of the Fukushima nuclear reactor accident: radiation effects on the thyroid and strategies for prevention. Curr Opin Endocrinol Diabetes Obes. 2014;21:384–93. doi: 10.1097/MED.0000000000000098.CrossRefPubMedGoogle Scholar
  24. 24.
    Nikiforov YE. Radiation-induced thyroid cancer: what we have learned from chernobyl. Endocr Pathol. 2006;17:307–17.CrossRefPubMedGoogle Scholar
  25. 25.
    Haugen BR, et al. 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133. doi: 10.1089/thy.2015.0020.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Carcangiu ML, Bianchi S, Savino D, Voynick IM, Rosai J. Follicular Hurthle cell tumors of the thyroid gland. Cancer. 1991;68:1944–53.CrossRefPubMedGoogle Scholar
  27. 27.
    Rosen IB, Luk S, Katz I. Hurthle cell tumor behavior: dilemma and resolution. Surgery. 1985;98:777–83.PubMedGoogle Scholar
  28. 28.
    Stojadinovic A, et al. Hurthle cell carcinoma: a 60-year experience. Ann Surg Oncol. 2002;9:197–203.PubMedGoogle Scholar
  29. 29.
    Cibas ES, Ali SZ, Conference, N. C. I. T. F. S. o. t. S. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol. 2009;132:658–65. doi: 10.1309/AJCPPHLWMI3JV4LA.CrossRefPubMedGoogle Scholar
  30. 30.
    Chandanwale SS, Gore CR, Bamanikar SA, Gupta N, Gupta K. Cytomorphologic spectrum of Hashimoto’s thyroiditis and its clinical correlation: a retrospective study of 52 patients. Cytojournal. 2014;11:9. doi: 10.4103/1742-6413.131741.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Dugan JM, Atkinson BF, Avitabile A, Schimmel M, LiVolsi VA. Psammoma bodies in fine needle aspirate of the thyroid in lymphocytic thyroiditis. Acta Cytol. 1987;31:330–4.PubMedGoogle Scholar
  32. 32.
    Montone KT, Baloch ZW, LiVolsi VA. The thyroid Hurthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review. Arch Pathol Lab Med. 2008;132:1241–50. doi:10.1043/1543-2165(2008)132[1241:TTHOCA]2.0.CO;2.PubMedGoogle Scholar
  33. 33.
    Faquin WC, Cibas ES, Renshaw AA. “Atypical” cells in fine-needle aspiration biopsy specimens of benign thyroid cysts. Cancer. 2005;105:71–9. doi: 10.1002/cncr.20832.CrossRefPubMedGoogle Scholar
  34. 34.
    Baloch ZW, LiVolsi VA. Cytologic and architectural mimics of papillary thyroid carcinoma. Diagnostic challenges in fine-needle aspiration and surgical pathology specimens. Am J Clin Pathol. 2006;125(Suppl):S135–44.PubMedGoogle Scholar
  35. 35.
    Solomon A, Gupta PK, LiVolsi VA, Baloch ZW. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens. Diagn Cytopathol. 2002;27:143–8. doi: 10.1002/dc.10156.CrossRefPubMedGoogle Scholar
  36. 36.
    Hui PK, Chan JK, Cheung PS, Gwi E. Columnar cell carcinoma of the thyroid. Fine needle aspiration findings in a case. Acta Cytol. 1990;34:355–8.PubMedGoogle Scholar
  37. 37.
    Ganly I, et al. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy. J Clin Endocrinol Metab. 2013;98:E962–72. doi: 10.1210/jc.2012-3539.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Kini SR, Miller JM, Hamburger JI. Cytopathology of Hurthle cell lesions of the thyroid gland by fine needle aspiration. Acta Cytol. 1981;25:647–52.PubMedGoogle Scholar
  39. 39.
    Yang YJ, Khurana KK. Diagnostic utility of intracytoplasmic lumen and transgressing vessels in evaluation of Hurthle cell lesions by fine-needle aspiration. Arch Pathol Lab Med. 2001;125:1031–5. doi: 10.1043/0003-9985(2001)125<1031:DUOILA>2.0.CO;2.PubMedGoogle Scholar
  40. 40.
    Zeppa P, et al. Fine needle aspiration cytology of medullary thyroid carcinoma: a review of 18 cases. Cytopathology. 1990;1:35–44.CrossRefPubMedGoogle Scholar
  41. 41.
    Erickson LA, et al. Analysis of amyloid in medullary thyroid carcinoma by mass spectrometry-based proteomic analysis. Endocr Pathol. 2015;26:291–5. doi: 10.1007/s12022-015-9390-7.CrossRefPubMedGoogle Scholar
  42. 42.
    Guiter GE, Auger M, Ali SZ, Allen EA, Zakowski MF. Cytopathology of insular carcinoma of the thyroid. Cancer. 1999;87:196–202.CrossRefPubMedGoogle Scholar
  43. 43.
    Gong Y, Krishnamurthy S. Fine-needle aspiration of an unusual case of poorly differentiated insular carcinoma of the thyroid. Diagn Cytopathol. 2005;32:103–7. doi: 10.1002/dc.20178.CrossRefPubMedGoogle Scholar
  44. 44.
    Rivera M, Sang C, Gerhard R, Ghossein R, Lin O. Anaplastic thyroid carcinoma: morphologic findings and PAX-8 expression in cytology specimens. Acta Cytol. 2010;54:668–72.CrossRefPubMedGoogle Scholar
  45. 45.
    Morgen EK, Geddie W, Boerner S, Bailey D, Santos Gda C. The role of fine-needle aspiration in the diagnosis of thyroid lymphoma: a retrospective study of nine cases and review of published series. J Clin Pathol. 2010;63:129–33. doi: 10.1136/jcp.2009.071423.CrossRefPubMedGoogle Scholar
  46. 46.
    Matsushima AY, Hamele-Bena D, Osborne BM. Fine-needle aspiration biopsy findings in marginal zone B cell lymphoma. Diagn Cytopathol. 1999;20:190–8.CrossRefPubMedGoogle Scholar
  47. 47.
    Kaba S, et al. Cytologic findings of primary thyroid MALT lymphoma with extreme plasma cell differentiation: FNA cytology of two cases. Diagn Cytopathol. 2009;37:815–9. doi: 10.1002/dc.21106.CrossRefPubMedGoogle Scholar
  48. 48.
    Chen H, Nicol TL, Udelsman R. Clinically significant, isolated metastatic disease to the thyroid gland. World J Surg. 1999;23:177–180.discussion 181.CrossRefPubMedGoogle Scholar
  49. 49.
    Hegerova L, Griebeler ML, Reynolds JP, Henry MR, Gharib H. Metastasis to the thyroid gland: report of a large series from the Mayo Clinic. Am J Clin Oncol. 2015;38:338–42. doi: 10.1097/COC.0b013e31829d1d09.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Michael Rivera
    • 1
  • Jennifer L. Sauter
    • 1
  • Michael R. Henry
    • 1
  1. 1.Anatomic PathologyMayo ClinicRochesterUSA

Personalised recommendations